Hefeng shares: by the end of August, it had bought back 1.11% of its shares

GlaxoSmithKline in China: Challenges Faced

China is undoubtedly the largest source of income for multinational pharmaceutical enterprises, and it is also the market they attach the most importance to. This article mainly analyzes the annual report of GSK to study its development in China and the challenges it faces.

Bennu Biotherapeutics Bags Over CNY 100 Mn in Angel+ Financing Round

Biotech Bennu Biotherapeutics, focusing on the R&D and conversion of cutting-edge technologies in the cell therapy, will continue to contribute to global innovative cellular therapies for oncology and autoimmune diseases with the fresh proceeds.

A Quick Look at The Semiconductor Industry: 60 Players of Key Fields [2/2]

In the past 50 years, the breakthrough technologies of semiconductors have made electronic devices smaller, more stable and available, transforming our way of life and work thoroughly. We at EqualOcean selected 60 Chinese players working in different niche markets in the industry for your reference.

Chiplet Provider KiwiMoore Bags CNY 100 Million in Angle Round

KiwiMoore, a provider of chiplet products and services, harvests an angle financing round worth CNY 100 million (USD 14.78 million), led by CASSTAR.

PhiGent Robotics Completed the Second Settlement of Its Series A over CNY 100 Million

Founded in August 2021, PhiGent Robotics specializes in the R&D of next-generation self-driving centered on visual 3D understanding.